The FOXP3+ Pro-inflammatory T Cell: A Potential Therapeutic Target in Crohn’s Disease

Scientists overlapped differentially expressed genes with publicly available microarray datasets and performed functional in vitro studies, including an in vitro suppression assay and organoid systems, to model gene expression changes observed in Crohn’s disease Tregs and to test predicted therapeutics.